Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × Taxes × 90 days × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 14 Ovarian Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Fallopian Tube Neoplasms 10 Neoplasm Metastasis 9 Lung Neoplasms 7 Endometrial Neoplasms 7 Breast Neoplasms 6 Triple Negative Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Oropharyngeal Neoplasms 3 Mouth Neoplasms 3 Laryngeal Neoplasms 3 Hypopharyngeal Neoplasms 3 Carcinoma 3 Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Transitional Cell 2 Carcinoma, Squamous Cell 2 Brenner Tumor 2 Anatomic Stage II Breast Cancer AJCC v8 2 Adenocarcinoma of Lung 2 Adenocarcinoma Of Esophagus 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Sinonasal Squamous Cell Carcinoma 1

Interventions

Cyclophosphamide 3 Biopsy 3 Azacitidine 3 Prednisone 2 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2 Doxorubicin 2 tislelizumab 1 tazemetostat 1 sodium-iodide symporter 1 selinexor 1 ruxolitinib 1 romidepsin 1 relatlimab 1 pembrolizumab 1 ivarmacitinib 1 gemcitabine-oxaliplatin regimen 1 fludarabine 1 etoposide phosphate 1 duvelisib 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 cc-486 1 belinostat 1 X-Rays 1 Vincristine 1 Spinal Puncture 1 Specimen Handling 1 Salvage Therapy 1 Prednisolone 1 Photons 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡